Approach to the Workup and Management of Headache in the Emergency Department and Inpatient Settings

Abstract

The challenge of headache management in the hospital can be divided into the diagnostic and management issues encountered in the emergency department, and the issues involved in the inpatient management of chronic refractory headaches. The two endeavors are different but linked because of overlapping diagnostic and treatment options. In addition, the problem of the intractable acute headache encountered in the emergency department can evolve into inpatient care of the same patient who has failed to respond to acute treatment. Here the author presents an approach to the patient with severe acute headache in the emergency department and explores the options available for managing intractable headaches in the inpatient setting.

Keywords

headache - migraine - emergency - inpatient

• References

• 1 Lucado J, Paez K, Elixhauser A. Headaches in U.S. Hospitals and Emergency Departments, 2008. HCUP Statistical Brief #111. Rockville, MD: Agency for Healthcare Research and Quality; 2011
• 2 Goldstein JN, Camargo Jr CA, Pelletier AJ, Edlow JA. Headache in United States emergency departments: demographics, work-up and frequency of pathological diagnoses. Cephalalgia 2006; 26 (6) 684-690
• 3 Edlow JA, Panagos PD, Godwin SA, Thomas TL, Decker WW ; American College of Emergency Physicians. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute headache. Ann Emerg Med 2008; 52 (4) 407-436
• 4 Alons IME, van den Wijngaard IR, Verheul RJ , et al. The value of CT angiography in patients with acute severe headache. Acta Neurol Scand 2015; 131 (3) 164-168
• 5 Sahai-Srivastava S, Desai P, Zheng L. Analysis of headache management in a busy emergency room in the United States. Headache 2008; 48 (6) 931-938
• 6 Gupta MX, Silberstein SD, Young WB, Hopkins M, Lopez BL, Samsa GP. Less is not more: underutilization of headache medications in a university hospital emergency department. Headache 2007; 47 (8) 1125-1133
• 7 Byyny RL, Mower WR, Shum N, Gabayan GZ, Fang S, Baraff LJ. Sensitivity of noncontrast cranial computed tomography for the emergency department diagnosis of subarachnoid hemorrhage. Ann Emerg Med 2008; 51 (6) 697-703
• 8 Cameron JD, Lane PL, Speechley M. Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache. Acad Emerg Med 1995; 2 (7) 597-602
• 9 Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT. A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department. Ann Emerg Med 2010; 56 (1) 1-6
• 10 Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 2: neuroleptics, antihistamines, and others. Headache 2012; 52 (2) 292-306
• 11 Friedman BW, Garber L, Yoon A , et al. Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine. Neurology 2014; 82 (11) 976-983
• 12 Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 1: triptans, dihydroergotamine, and magnesium. Headache 2012; 52 (1) 114-128
• 13 Seim MB, March JA, Dunn KA. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med 1998; 5 (6) 573-576
• 14 Shrestha M, Singh R, Moreden J, Hayes JE. Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial. Arch Intern Med 1996; 156 (15) 1725-1728
• 15 Taggart E, Doran S, Kokotillo A, Campbell S, Villa-Roel C, Rowe BH. Ketorolac in the treatment of acute migraine: a systematic review. Headache 2013; 53 (2) 277-287
• 16 Gertsch E, Loharuka S, Wolter-Warmerdam K, Tong S, Kempe A, Kedia S. Intravenous magnesium as acute treatment for headaches: a pediatric case series. J Emerg Med 2014; 46 (2) 308-312
• 17 Demirkaya S, Vural O, Dora B, Topçuoğlu MA. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache 2001; 41: 171-177
• 18 Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications. Headache 2012; 52 (3) 467-482
• 19 Tepper SJ. Opioids should not be used in migraine. Headache 2012; 52 (Suppl. 01) 30-34
• 20 Tornabene SV, Deutsch R, Davis DP, Chan TC, Vilke GM. Evaluating the use and timing of opioids for the treatment of migraine headaches in the emergency department. J Emerg Med 2009; 36 (4) 333-337
• 21 Colman I, Friedman BW, Brown MD , et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ 2008; 336 (7657) 1359-1361
• 22 Ashkenazi A, Blumenfeld A, Napchan U , et al; Interventional Procedures Special Interest Section of the American. Peripheral nerve blocks and trigger point injections in headache management - a systematic review and suggestions for future research. Headache 2010; 50 (6) 943-952
• 23 Ashkenazi A, Matro R, Shaw JW, Abbas MA, Silberstein SD. Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study. J Neurol Neurosurg Psychiatry 2008; 79 (4) 415-417
• 24 Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med 2004; 43 (2) 256-262
• 25 Leung S, Bulloch B, Young C, Yonker M, Hostetler M. Effectiveness of standardized combination therapy for migraine treatment in the pediatric emergency department. Headache 2013; 53 (3) 491-197
• 26 Bachur RG, Monuteaux MC, Neuman MI. A comparison of acute treatment regimens for migraine in the emergency department. Pediatrics 2015; 135 (2) 232-238
• 27 Ducharme J. Canadian Association of Emergency Physicians guidelines for the acute management of migraine headache. J Emerg Med 1999; 17 (1) 137-144
• 28 Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992; 267 (1) 64-69
• 29 Diamond S, Freitag FG, Maliszewski M. Inpatient treatment of headache: long-term results. Headache 1986; 26 (4) 189-197
• 30 Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986; 36 (7) 995-997
• 31 Silberstein SD, Silberstein JR. Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE. Headache 1992; 32 (9) 439-445
• 32 Nagy AJ, Gandhi S, Bhola R, Goadsby PJ. Intravenous dihydroergotamine for inpatient management of refractory primary headaches. Neurology 2011; 77 (20) 1827-1832
• 33 Mathew NT, Kailasam J. Repetitive intravenous administration of valproate sodium in intractable migraine: comparison with intravenous dihydroergotamine (DHE). Neurology 2000; 54: A22 (abstract)
• 34 Krusz JC, Scott V, Belanger J. Intravenous propofol: unique effectiveness in treating intractable migraine. Headache 2000; 40 (3) 224-230
• 35 Mendes PM, Silberstein SD, Young WB, Rozen TD, Paolone MF. Intravenous propofol in the treatment of refractory headache. Headache 2002; 42 (7) 638-641
• 36 Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia 2003; 23 (10) 963-971
• 37 Rosen N, Marmura M, Abbas M, Silberstein S. Intravenous lidocaine in the treatment of refractory headache: a retrospective case series. Headache 2009; 49 (2) 286-291
• 38 Linder SL. Treatment of acute childhood migraine headaches. Cephalalgia 1991; 11 (Suppl. 11) 120-121
• 39 Kabbouche MA, Powers SW, Segers A , et al. Inpatient treatment of status migraine with dihydroergotamine in children and adolescents. Headache 2009; 49 (1) 106-109
• 40 Lanzi G, D'Arrigo S, Termine C , et al. The effectiveness of hospitalization in the treatment of paediatric idiopathic headache patients. Psychopathology 2007; 40 (1) 1-7